Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This study will determine the effects of omega-3 fatty acid (FA) augmentation of sertraline
on depression and cardiac endpoints after myocardial infarction (MI).